Cargando…

Carrier-Induced Hyporesponsiveness to Pneumococcal Conjugate Vaccines: Unraveling the Influence of Serotypes, Timing, and Previous Vaccine Dose

BACKGROUND: Pneumococcal conjugate vaccines (PCVs) elicit lower immune response against serotypes carried before or at the time of vaccination (hyporesponsiveness) in infants. The limited studies conducted to date did not permit comprehensive insights regarding this phenomenon. This study, the large...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dagan, Ron, Jiang, Qin, Juergens, Christine, Trammel, James, Gruber, William C, Scott, Daniel A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Major Articles and Commentaries
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7850554/ https://www.ncbi.nlm.nih.gov/pubmed/31995183 http://dx.doi.org/10.1093/cid/ciaa083

Ejemplares similares

Late onset of injection site reactions after vaccination with the 13-valent pneumococcal conjugate vaccine in adult study populations
por: Juergens, Christine, et al.
Publicado: (2018)

Persistence of Nasopharyngeal Pneumococcal Vaccine Serotypes and Increase of Nonvaccine Serotypes Among Vaccinated Infants and Their Mothers 5 Years After Introduction of Pneumococcal Conjugate Vaccine 13 in The Gambia
por: Usuf, Effua, et al.
Publicado: (2019)

Pneumococcal Conjugate Vaccine Safety in Elderly Adults
por: Tseng, Hung Fu, et al.
Publicado: (2018)

Post–13-Valent Pneumococcal Conjugate Vaccine Dynamics in Young Children of Serotypes Included in Candidate Extended-Spectrum Conjugate Vaccines
por: Ben-Shimol, Shalom, et al.
Publicado: (2021)

Pneumococcal Carriage, Serotype Distribution, and Risk Factors in Children With Community-Acquired Pneumonia, 5 Years After Introduction of the 10-Valent Pneumococcal Conjugate Vaccine in Ethiopia
por: Negash, Abel Abera, et al.
Publicado: (2019)

Serotype-specific Cardiac Involvement in Pneumococcal Pneumonia
por: Klugman, Keith P, et al.
Publicado: (2020)

Declines in Pneumonia Mortality Following the Introduction of Pneumococcal Conjugate Vaccines in Latin American and Caribbean Countries
por: de Oliveira, Lucia H, et al.
Publicado: (2020)

Distribution of Serotypes Causing Invasive Pneumococcal Disease in Children From High-Income Countries and the Impact of Pediatric Pneumococcal Vaccination
por: Grant, Lindsay R, et al.
Publicado: (2022)

Impact of Pneumococcal Conjugate Vaccine on Vaccine Serotype–Specific Pneumonia
por: Klugman, Keith P, et al.
Publicado: (2020)

Comparison of the Impact of Pneumococcal Conjugate Vaccine 10 or Pneumococcal Conjugate Vaccine 13 on Invasive Pneumococcal Disease in Equivalent Populations
por: Naucler, Pontus, et al.
Publicado: (2017)

Evaluating post-vaccine expansion patterns of pneumococcal serotypes
por: Phillips, Maile T., et al.
Publicado: (2020)

Optimal Serotype Compositions for Pneumococcal Conjugate Vaccination under Serotype Replacement
por: Nurhonen, Markku, et al.
Publicado: (2014)

Pneumococcal vaccination in persons living with HIV: Pneumococcal conjugate, polysaccharide or both?
por: Dhingra, Bhavna, et al.
Publicado: (2020)

Immunogenicity, Safety, and Tolerability of 13-Valent Pneumococcal Conjugate Vaccine Followed by 23-Valent Pneumococcal Polysaccharide Vaccine in Recipients of Allogeneic Hematopoietic Stem Cell Transplant Aged ≥2 Years: An Open-Label Study
por: Cordonnier, Catherine, et al.
Publicado: (2015)

Characterization of pneumococcal serotype 7F in vaccine conjugation
por: Deng, James Z, et al.
Publicado: (2023)

Immunogenicity of an Additional mRNA-1273 SARS-CoV-2 Vaccination in People With HIV With Hyporesponse After Primary Vaccination
por: Jongkees, Marlou J, et al.
Publicado: (2022)

Vaccine-Preventable Disease Incidence Based on Clinically, Radiologically, and Etiologically Confirmed Outcomes: Systematic Literature Review and Re-analysis of Pneumococcal Conjugate Vaccine Efficacy Trials
por: Bollaerts, Kaatje, et al.
Publicado: (2021)

Insight Into Resistance Phenotypes of Emergent Non 13-valent Pneumococcal Conjugate Vaccine Type Pneumococci Isolated From Invasive Disease After 13-valent Pneumococcal Conjugate Vaccine Implementation in France
por: Janoir, Claire, et al.
Publicado: (2016)

Pneumococcal conjugate vaccine induced IgG and nasopharyngeal carriage of pneumococci: Hyporesponsiveness and immune correlates of protection for carriage
por: Ojal, John, et al.
Publicado: (2017)

1728. Immune Responses to Cross-Reactive Serotypes 6C and 15C After 20-Valent Pneumococcal Conjugate Vaccine in Infants
por: Tamimi, Noor, et al.
Publicado: (2023)

The Serotype Distribution among Healthy Carriers before Vaccination Is Essential for Predicting the Impact of Pneumococcal Conjugate Vaccine on Invasive Disease
por: Flasche, Stefan, et al.
Publicado: (2015)

Effect of Age and Vaccination With a Pneumococcal Conjugate Vaccine on the Density of Pneumococcal Nasopharyngeal Carriage
por: Roca, A., et al.
Publicado: (2012)

Surveillance of the impact of pneumococcal conjugate vaccines in developing countries
por: Rodgers, Gail L, et al.
Publicado: (2015)

Immunogenicity, Safety, and Tolerability of V114, a 15-Valent Pneumococcal Conjugate Vaccine, in Immunocompetent Adults Aged 18–49 Years With or Without Risk Factors for Pneumococcal Disease: A Randomized Phase 3 Trial (PNEU-DAY)
por: Hammitt, Laura L, et al.
Publicado: (2021)

Serotypes in Adult Pneumococcal Pneumonia in Spain in the Era of Conjugate Vaccines
por: Fernández-Delgado, Lucía, et al.
Publicado: (2021)

Changes in the Pneumococcal Vaccine Serotypes in Adult Noninvasive Pneumonia after the Introduction of Pneumococcal Conjugate Vaccination for Children
por: Takeda, Hiroaki, et al.
Publicado: (2019)

Immunogenicity and safety of the 13-valent pneumococcal conjugate vaccine compared to the 23-valent pneumococcal polysaccharide vaccine in elderly Japanese adults
por: Shiramoto, Masanari, et al.
Publicado: (2015)

Nasopharyngeal Carriage of Pneumococcus in Children in England up to 10 Years After 13-Valent Pneumococcal Conjugate Vaccine Introduction: Persistence of Serotypes 3 and 19A and Emergence of 7C
por: Tiley, Karen S, et al.
Publicado: (2022)

Thirteen-Valent Pneumococcal Conjugate Vaccine–Induced Immunoglobulin G (IgG) Responses in Serum Associated With Serotype-Specific IgG in the Lung
por: Mitsi, Elena, et al.
Publicado: (2021)

Differences in Homing Potentials of Streptococcus pneumoniae–Specific Plasmablasts in Pneumococcal Pneumonia and After Pneumococcal Polysaccharide and Pneumococcal Conjugate Vaccinations
por: Palkola, Nina V., et al.
Publicado: (2015)

Pivotal Phase 3 Randomized Clinical Trial of the Safety, Tolerability, and Immunogenicity of 20-Valent Pneumococcal Conjugate Vaccine in Adults Aged ≥18 Years
por: Essink, Brandon, et al.
Publicado: (2021)

Evolution of pneumococcal serotype epidemiology in Botswana following introduction of 13-valent pneumococcal conjugate vaccine
por: Patel, Sweta M., et al.
Publicado: (2022)

Rapid replacement by non-vaccine pneumococcal serotypes may mitigate the impact of the pneumococcal conjugate vaccine on nasopharyngeal bacterial ecology
por: Kwambana-Adams, Brenda, et al.
Publicado: (2017)

Knowledge of serotype prevalence & burden of invasive pneumococcal disease: a prerequisite to vaccine introduction in the country
por: Kanungo, Reba
Publicado: (2015)

Expanded Analysis of 20 Pneumococcal Serotypes Associated With Radiographically Confirmed Community-acquired Pneumonia in Hospitalized US Adults
por: Isturiz, Raul, et al.
Publicado: (2021)

Chronic Disease and Immunosuppression Increase the Risk for Nonvaccine Serotype Pneumococcal Disease: A Nationwide Population-based Study
por: Naucler, Pontus, et al.
Publicado: (2021)

The Evolution and Distribution of Pneumococcal Serotypes in Adults Hospitalized With Community-Acquired Pneumonia in Spain Using a Serotype-Specific Urinary Antigen Detection Test: The CAPA Study, 2011–2018
por: Torres, Antoni, et al.
Publicado: (2021)

Pediatric Invasive Pneumococcal Disease Caused by Vaccine Serotypes following the Introduction of Conjugate Vaccination in Denmark
por: Harboe, Zitta B., et al.
Publicado: (2013)

Decline in Vaccine-Type Streptococcus pneumoniae Serotypes Following Pneumococcal Conjugate Vaccine Introduction in Madagascar
por: Raboba, Julia L, et al.
Publicado: (2021)

Safety and Immunogenicity of a 20-valent Pneumococcal Conjugate Vaccine in Healthy Infants in the United States
por: Senders, Shelly, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_sbrvcq0fjpqhbu0hn0hksb6ehs